Aclaris Therapeutics, Inc. (ACRS)
NASDAQ: ACRS · Real-Time Price · USD
1.810
+0.010 (0.56%)
Oct 31, 2024, 4:00 PM EDT - Market closed
Aclaris Therapeutics Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for ACRS stock has a target of 1.00, which predicts a decrease of -44.75% from the current stock price of 1.81.
Analyst Consensus: Hold
* Price targets were last updated on Dec 18, 2023.
Analyst Ratings
The average analyst rating for ACRS stock from 5 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 5 | 5 | 5 | 5 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 6 | 6 | 6 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Sep 17, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Aug 19, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Jul 22, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jan 22, 2024 |
| BTIG | BTIG | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jan 11, 2024 |
Financial Forecast
Revenue This Year
14.49M
from 31.25M
Decreased by -53.64%
Revenue Next Year
9.23M
from 14.49M
Decreased by -36.29%
EPS This Year
-0.61
from -1.27
EPS Next Year
-0.66
from -0.61
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 39.1M | 13.5M | 14.7M | ||
| Avg | 14.5M | 9.2M | 7.7M | ||
| Low | 6.3M | 2.5M | 2.5M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 25.0% | -6.5% | 59.3% | ||
| Avg | -53.6% | -36.3% | -16.7% | ||
| Low | -79.9% | -82.9% | -73.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.27 | -0.45 | -0.45 | ||
| Avg | -0.61 | -0.66 | -0.74 | ||
| Low | -0.75 | -0.86 | -0.93 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.